PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Idarucizumab - Anticoagulation reversal

PAD Profile : Idarucizumab - Anticoagulation reversal Important

Keywords :
anticoagulant reversal, dabigatran antidote, dabigatran reversal
Brand Names Include :
Praxbind
Important Information :
Dabigatran anticoagulant reversal. RESTRICTED to Haematologists only

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Intravenous infusion
  • Intravenous injection (IV)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

No committee recommendations returned.

Associated BNF Codes

02. Cardiovascular System
02.08.04. Idarucizumab
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More